TERESE GHIO for ARENA PHARMACEUTICALS, INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
TAX: R&D tax credit, Net Operating Loss, Therapeutic Discovery tax credit; MMM: Patient access to obesity and weight loss treatment; HCR: obesity prevention and treatment in the healthcare reform bills; CPT: Patent Reform Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TERESE MARIE GHIO New | — |
Copyright/Patent/Trademark CPT
TAX: R&D tax credit, Net Operating Loss, Therapeutic Discovery tax credit; MMM: Patient access to obesity and weight loss treatment; HCR: obesity prevention and treatment in the healthcare reform bills; CPT: Patent Reform Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TERESE MARIE GHIO New | — |
Medicare/Medicaid MMM
TAX: R&D tax credit, Net Operating Loss, Therapeutic Discovery tax credit; MMM: Patient access to obesity and weight loss treatment; HCR: obesity prevention and treatment in the healthcare reform bills; CPT: Patent Reform Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TERESE MARIE GHIO New | — |
Taxation/Internal Revenue Code TAX
TAX: R&D tax credit, Net Operating Loss, Therapeutic Discovery tax credit; MMM: Patient access to obesity and weight loss treatment; HCR: obesity prevention and treatment in the healthcare reform bills; CPT: Patent Reform Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TERESE MARIE GHIO New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.